Padres Pedal the Cause has raised $24+ million by mobilizing survivors, families, friends, doctors, scientists, corporate partners, and volunteers.

Dr. Paula Aristizabal, a research partner scientist at Rady Children’s Hospital, who also leads Curebound’s Cancer Equities committee as a member of the Scientific Advisory Board

In chart-topping English singer-songwriter Sheeran, Curebound has a headliner who is one of the biggest live-music attractions in the world.

Researchers say changes in how the National Institutes of Health approve and distribute grants are putting patients, cures and the entire biotech industry in peril.

The Grammy winning superstar follows in the footsteps of fellow music stars to have headlined in years past like Elton John, Ed Sheeran and Alicia Keys.

New board members bring expertise and strategic insight across biotechnology, digital health, finance, entrepreneurship, and nonprofit governance.

SAN DIEGO – January 20, 2026 – Curebound, a rapidly growing philanthropic organization dedicated to funding breakthrough cancer research, today announced the appointment of Rick Valencia as Chair of its Board of Directors

Pancreatic cancer is one of the deadliest diagnoses a patient can get – especially if patients are not diagnosed until it is in an advanced stage. A team of researchers led by UC San Diego Associate Professor of Cellular and Molecular Medicine

This is the new reality of cancer research in America, where a $1.8 billion federal funding cut across the National Institutes of Health has transformed San Diego County nonprofits and private donors into lifelines. 

Founding CEO Anne Marbarger to join board of directors and serve as advisor.

Over 3,000 riders, runners, walkers, and spinners joined forces at UC San Diego last month for the 2025 Curebound Cancer Challenge (formerly Padres Pedal the Cause), generating an outpouring of community support.

Cue the cowbells, hoots, hollers and signs of encouragement. On August 2, the University of California San Diego will host the Curebound Cancer Challenge, with cancer patients, survivors, doctors...

Curebound launches all-new Curebound Cancer Challenge event and calls on individuals, corporations, and philanthropists to join together to support.

Twenty-seven-thousand San Diegans filled Petco Park on Friday, May 9 with snazzy suits, bedazzled jackets and sequined Dodgers gear for a one-night only show by musical superstar Elton John while fundraising for Curebound.

Elton John was given a returning hero’s welcome by the 27,000-strong audience. The concert raised $11.5 million for Curebound, the San Diego nonprofit that funds adult and pediatric cancer research.

The concert will raise money for cancer research, and mark one of musician's few major live events since retiring from the road in 2023.

The legendary singer-songwriter will perform May 9 at Petco Park, where he will headline the 2025 Concerts for Cures to raise funds for Curebound, whose previous benefit concerts here have featured Alicia Keys and Ed Sheeran.

Philanthropic organization has awarded $43 million in cancer research to date, awarding 142 study grants with one vision: cures in our lifetime.

$43 million invested in research for 23 types of cancer by Curebound so far; call to community during season of giving to help in fight against cancer

Music lover, car enthusiast, attorney, businessperson - Ralph Whitworth was well known in Rancho Sante Fe and throughout San Diego for his great talents and large personality.

Curebound launched its new Curebound Cancer Challenge today. An evolution of Curebound’s renowned Padres Pedal the Cause event

Named in honor of activist investor Ralph Whitworth, the new Curebound philanthropic group led by his wife Fernanda Whitworth

The Cure Prize challenge is to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in three-five years.

Research could lead to next-generation immunotherapy for head and neck cancer patients, and may have broad impact on treatments for other types of cancer.

Precision oncology aims to optimally select treatment for each patient with cancer by first identifying and subsequently targeting molecular defects in the patient's tumor.

"Curebound funding was critical to expanding our pilot program into an NCI-funded clinical trial..."

Padres Pedal the Cause has raised $24+ million by mobilizing survivors, families, friends, doctors, scientists, corporate partners, and volunteers.

Dr. Paula Aristizabal, a research partner scientist at Rady Children’s Hospital, who also leads Curebound’s Cancer Equities committee as a member of the Scientific Advisory Board

In chart-topping English singer-songwriter Sheeran, Curebound has a headliner who is one of the biggest live-music attractions in the world.